Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Duchenne Muscular Dystrophy (DMD) Therapeutics market will register a 43.7%% CAGR in terms of revenue, the global market size will reach $ 2801.6 million by 2025, from $ 657.5 million in 2019. In particular, this report presents the global revenue market share of key companies in Duchenne Muscular Dystrophy (DMD) Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Duchenne Muscular Dystrophy (DMD) Therapeutics market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Duchenne Muscular Dystrophy (DMD) Therapeutics, covering the supply chain analysis, impact assessment to the Duchenne Muscular Dystrophy (DMD) Therapeutics market size growth rate in several scenarios, and the measures to be undertaken by Duchenne Muscular Dystrophy (DMD) Therapeutics companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Exondys 51
Emflaza
Translarna
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospitals
Clinics
Home Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sarepta Therapeutics
PTC Therapeutics
Bristol-Myers Squibb
Italfarmaco
Pfizer
Santhera Pharmaceuticals
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Duchenne Muscular Dystrophy (DMD) Therapeutics market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Duchenne Muscular Dystrophy (DMD) Therapeutics market by identifying its various subsegments.
Focuses on the key global Duchenne Muscular Dystrophy (DMD) Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Duchenne Muscular Dystrophy (DMD) Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Duchenne Muscular Dystrophy (DMD) Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2015-2025
2.1.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size CAGR by Region
2.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Segment by Type
2.2.1 Exondys 51
2.2.2 Exondys 51
2.2.3 Translarna
2.3 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type
2.3.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2015-2020)
2.3.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth Rate by Type (2015-2020)
2.4 Duchenne Muscular Dystrophy (DMD) Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home Care
2.5 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application
2.5.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2015-2020)
2.5.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth Rate by Application (2015-2020)
3 Global Duchenne Muscular Dystrophy (DMD) Therapeutics by Players
3.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Players
3.1.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Players (2018-2020)
3.1.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Players (2018-2020)
3.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Duchenne Muscular Dystrophy (DMD) Therapeutics by Regions
4.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Regions
4.2 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth
4.3 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth
4.4 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth
4.5 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth
5 Americas
5.1 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Countries
5.2 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type
5.3 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Regions
6.2 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type
6.3 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics by Countries
7.2 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type
7.3 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics by Countries
8.2 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type
8.3 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast (2021-2025)
10.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Regions
10.2.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Type
10.8 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Application
11 Key Players Analysis
11.1 Sarepta Therapeutics
11.1.1 Company Details
11.1.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.1.3 Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Sarepta Therapeutics News
11.2 PTC Therapeutics
11.2.1 Company Details
11.2.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.2.3 PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 PTC Therapeutics News
11.3 Bristol-Myers Squibb
11.3.1 Company Details
11.3.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.3.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Bristol-Myers Squibb News
11.4 Italfarmaco
11.4.1 Company Details
11.4.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.4.3 Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Italfarmaco News
11.5 Pfizer
11.5.1 Company Details
11.5.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.5.3 Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Pfizer News
11.6 Santhera Pharmaceuticals
11.6.1 Company Details
11.6.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.6.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Santhera Pharmaceuticals News
...
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Exondys 51
Table 5. Major Players of Emflaza
Table 6. Major Players of Translarna
Table 7. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2014-2019) ($ Millions)
Table 8. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2015-2020)
Table 9. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 10. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2015-2020)
Table 11. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue by Players (2018-2020) ($ Millions)
Table 12. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share by Players (2018-2020)
Table 13. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Key Players Head office and Products Offered
Table 14. Duchenne Muscular Dystrophy (DMD) Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Regions 2015-2020 ($ Millions)
Table 18. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Regions 2015-2020
Table 19. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 20. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Countries (2015-2020)
Table 21. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 22. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2015-2020)
Table 23. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 24. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2015-2020)
Table 25. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Regions (2015-2020) ($ Millions)
Table 26. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Regions (2015-2020)
Table 27. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 28. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2015-2020)
Table 29. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 30. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2015-2020)
Table 31. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 32. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Countries (2015-2020)
Table 33. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 34. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2015-2020)
Table 35. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 36. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2015-2020)
Table 37. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 38. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Countries (2015-2020)
Table 39. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 40. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2015-2020)
Table 41. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 42. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2015-2020)
Table 43. Key and Potential Regions of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table 44. Key Application and Potential Industries of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table 45. Key Challenges of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table 46. Key Trends of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table 47. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 48. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share Forecast by Regions
Table 49. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Type (2021-2025) ($ Millions)
Table 50. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share Forecast by Type (2021-2025)
Table 51. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Application (2021-2025) ($ Millions)
Table 52. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share Forecast by Application (2021-2025)
Table 53. Sarepta Therapeutics Details, Company Total Revenue (in $ million), Head Office, Duchenne Muscular Dystrophy (DMD) Therapeutics Major Market Areas and Its Competitors
Table 54. Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 55. Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Gross Margin (2018-2020E)
Table 56. Sarepta Therapeutics Main Business
Table 57. Sarepta Therapeutics Latest Developments
Table 58. PTC Therapeutics Details, Company Total Revenue (in $ million), Head Office, Duchenne Muscular Dystrophy (DMD) Therapeutics Major Market Areas and Its Competitors
Table 59. PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 60. PTC Therapeutics Main Business
Table 61. PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Gross Margin (2018-2020E)
Table 62. PTC Therapeutics Latest Developments
Table 63. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Duchenne Muscular Dystrophy (DMD) Therapeutics Major Market Areas and Its Competitors
Table 64. Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 65. Bristol-Myers Squibb Main Business
Table 66. Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Gross Margin (2018-2020E)
Table 67. Bristol-Myers Squibb Latest Developments
Table 68. Italfarmaco Details, Company Total Revenue (in $ million), Head Office, Duchenne Muscular Dystrophy (DMD) Therapeutics Major Market Areas and Its Competitors
Table 69. Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 70. Italfarmaco Main Business
Table 71. Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Gross Margin (2018-2020E)
Table 72. Italfarmaco Latest Developments
Table 73. Pfizer Details, Company Total Revenue (in $ million), Head Office, Duchenne Muscular Dystrophy (DMD) Therapeutics Major Market Areas and Its Competitors
Table 74. Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Gross Margin (2018-2020E)
Table 77. Pfizer Latest Developments
Table 78. Santhera Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Duchenne Muscular Dystrophy (DMD) Therapeutics Major Market Areas and Its Competitors
Table 79. Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 80. Santhera Pharmaceuticals Main Business
Table 81. Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Gross Margin (2018-2020E)
Table 82. Santhera Pharmaceuticals Latest Developments
List of Figures
Figure 1. Duchenne Muscular Dystrophy (DMD) Therapeutics Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2015-2020)
Figure 5. Global Exondys 51 Market Size Growth Rate
Figure 6. Global Emflaza Market Size Growth Rate
Figure 7. Global Translarna Market Size Growth Rate
Figure 8. Duchenne Muscular Dystrophy (DMD) Therapeutics in Hospitals
Figure 9. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market: Hospitals (2015-2020) ($ Millions)
Figure 10. Duchenne Muscular Dystrophy (DMD) Therapeutics in Clinics
Figure 11. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market: Clinics (2015-2020) ($ Millions)
Figure 12. Duchenne Muscular Dystrophy (DMD) Therapeutics in Home Care
Figure 13. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market: Home Care (2015-2020) ($ Millions)
Figure 14. Global Home Care YoY Growth ($ Millions)
Figure 15. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2019
Figure 16. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Regions 2015-2020
Figure 17. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2015-2020 ($ Millions)
Figure 18. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2015-2020 ($ Millions)
Figure 19. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2015-2020 ($ Millions)
Figure 20. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2015-2020 ($ Millions)
Figure 21. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Countries in 2019
Figure 22. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type in 2019
Figure 23. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2019
Figure 24. United States Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 25. Canada Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 26. Mexico Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 27. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Regions in 2019
Figure 28. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type in 2019
Figure 29. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2019
Figure 30. China Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 31. Japan Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 32. Korea Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 33. Southeast Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 34. India Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 35. Australia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 36. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Countries in 2019
Figure 37. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type in 2019
Figure 38. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2019
Figure 39. Germany Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 40. France Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 41. UK Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 42. Italy Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 43. Russia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 44. Spain Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 45. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Countries in 2019
Figure 46. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type in 2019
Figure 47. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2019
Figure 48. Egypt Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 49. South Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 50. Israel Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 51. Turkey Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 52. GCC Countries Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 53. Global Duchenne Muscular Dystrophy (DMD) Therapeutics arket Size Forecast (2021-2025) ($ Millions)
Figure 54. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 55. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 56. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 57. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 58. United States Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 59. Canada Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 60. Mexico Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 61. Brazil Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 62. China Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 63. Japan Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 64. Korea Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 65. Southeast Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 66. India Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 67. Australia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 68. Germany Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 69. France Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 70. UK Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 71. Italy Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 72. Russia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 73. Spain Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 74. Egypt Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 75. South Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 76. Israel Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 77. Turkey Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
Figure 78. GCC Countries Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2021-2025 ($ Millions)
